Marietta, Ga. -- Solvay Pharmaceuticals, Inc. today announced that Amanda Rudd has been awarded the title of 2009 Thriving Student Achiever for her creative entry expressing her dream for the future.

In honor of the 17th year of the SolvayCARESSM scholarship program, Amanda was awarded an educational scholarship totaling $17,000. In September, Solvay Pharmaceuticals, Inc. announced that 40 students with cystic fibrosis (CF) who are pursuing higher education had each been awarded SolvayCARESSM scholarships and were eligible to be named the 2009 Thriving Student Achiever through a month-long, public voting period. Amanda's entry, which received the most votes, along with those of the other scholarship recipients, can be viewed at www.SolvayCARESScholarship.com.

"CF is a part of me and who I am, but it runs alongside me and does not stand in my way," said Amanda Rudd, 2009 SolvayCARESSM Thriving Student Achiever and student at Salt Lake Community College, Salt Lake City, Utah. "Earning the Thriving Student Achiever scholarship has lifted some of the financial burden of attending college so that I can focus on my studies to become a dental hygienist."

In 2009, Solvay Pharmaceuticals, Inc. has awarded scholarships totaling more than $200,000 to nearly 250 students living with CF through its SolvayCARESSM Scholarship program. Each year, 40 students receive a one-year scholarship of $2,500 to help finance post-secondary education; however, as a special recognition this year, every eligible 2009 applicant was honored with a $500 scholarship. Profiles, including essays and creative presentations, featuring the 40 scholarship recipients, including the Thriving Student Achiever, can be viewed online at www.SolvayCARESScholarship.com.

"Solvay Pharmaceuticals congratulates Amanda on being named the 2009 Thriving Student Achiever," said Dr. Stephen Hill, president of Solvay Pharmaceuticals, Inc. "She embodies the positive attitude and spirit of all of our outstanding scholarship recipients, who are each role models for the CF community."

Since 1993, Solvay Pharmaceuticals has donated more than $2 million dollars in scholarships to high-achieving students with CF. For more information about the SolvayCARESSM Scholarship program, please visit www.SolvayCARESScholarship.com.

Cystic fibrosis is an inherited chronic disease that affects the lungs and digestive system of about 30,000 children and adults in the United States. Cystic fibrosis presents extraordinary health burdens for patients and financial challenges for their families. Thanks to tremendous advances in medical treatments, more young adults with CF are living longer, healthier lives than ever before, and many more are pursuing dreams of higher education. Today, more than 40 percent of people living with CF are aged 18 or older.1
About SolvayCARESSM

For more than 20 years, Solvay Pharmaceuticals has offered a variety of resources – including nutritional, educational and financial assistance – to support those living with CF throughout each stage of life. SolvayCARESSM provides nutritional support to eligible patients with free multivitamins in softgel, chewable, and liquid formulations plus a variety of nutritional drink choices. New this year in the realm of financial support, SolvayCARESSM offers a co-pay reduction to eligible patients. Since 1993, the program has awarded scholarships totaling more than $2 million to outstanding young adults with CF who are pursuing higher education. Through SolvayCARESSM, Solvay Pharmaceuticals also partners with other organizations in the battle against CF, including the Cystic Fibrosis Foundation, and has been part of its Great Strides fundraiser since the event's inception in 1989. Solvay Pharmaceuticals supports the Boomer Esiason Foundation (BEF) as the primary sponsor of its Sacks for CF scholarship program. To learn more about the nutritional, educational and financial support available through SolvayCARESSM, please visit www.SolvayCARES.com.

Solvay Pharmaceuticals, Inc., of Marietta, Georgia, is the U.S. subsidiary of Solvay Pharmaceuticals. For more information, visit www.solvaypharmaceuticals-us.com.

Solvay Pharmaceuticals is a research driven group of companies that constitutes the global pharmaceutical business of the Solvay Group. These companies seek to fulfill carefully selected, unmet medical needs in the therapeutic areas of neuroscience, cardiometabolic, influenza vaccines, gastroenterology and men's and women's health. Its 2008 sales were EUR 2.7 billion and it employs more than 9,000 people worldwide. For more information, visit www.solvaypharmaceuticals.com.

Solvay is an international Chemicals and Pharmaceuticals Group with headquarters in Brussels. It employs some 28,300 people in 50 countries. In 2008, its sales amounted to EUR 9.5 billion generated by its three activity sectors: Chemicals, Plastics and Pharmaceuticals. Solvay (NYSE-Euronext: SOLB.BE - Bloomberg: SOLB.BB - Reuters: SOLBt.BR) is listed on NYSE-Euronext at Brussels. Details are available at www.solvay.com.

Press Contacts:
Jessica Riley
Solvay Pharmaceuticals, Inc.
(770) 578-5637
jessica.riley@solvay.com
Jane Petrino
Ruder Finn
(212) 593-5805
petrinoj@ruderfinn.com

References
1. Cystic Fibrosis Foundation. About Cystic Fibrosis. Accessed September 2009. http://www.cff.org/AboutCF/